BB Biotech AG/ CH0038389992 /
2024-08-30 5:05:23 PM | Chg. -0.35 | Volume | Bid5:20:00 PM | Ask5:45:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
38.95CHF | -0.89% | 4,912 Turnover: 191,807.10 |
-Bid Size: - | -Ask Size: - | 2.16 bill.CHF | 5.13% | - |
Assets
2013 US GAAP in mill. CHF |
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
2016 US GAAP in mill. CHF |
2017 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | - | - | - | - | - | ||||||
Intangible Assets | - | - | - | - | - | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | - | - | - | - | - | ||||||
Cash and Cash Equivalents | 43.7000 | 9 | 21.1000 | 10.2000 | 10.7000 | ||||||
Current Assets | 2,210.9000 | 3,532.8000 | 4,143.7000 | 3,226.2000 | 3,637.8000 | ||||||
Total Assets | 2,210.9000 | 3,532.8000 | 4,143.7000 | 3,226.2000 | 3,637.8000 |
Liabilities
2013 US GAAP in mill. CHF |
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
2016 US GAAP in mill. CHF |
2017 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | - | - | - | - | - | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 90.7000 | 36.7000 | 161.2000 | 219.6000 | 95 | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 92 | 40.3000 | 165.5000 | 223.2000 | 99.1000 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 2,118.9000 | 3,492.5000 | 3,978.2000 | 3,003 | 3,538.7000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 2,210.9000 | 3,532.8000 | 4,143.7000 | 3,226.2000 | 3,637.8000 |
Income Statement
2013 US GAAP in mill. CHF |
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
2016 US GAAP in mill. CHF |
2017 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 950.9000 | 1,499.4000 | 697.9000 | 9.5000 | 730 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 932 | 1,470.2000 | 652.9000 | -802 | 687.6000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | 931.8000 | 1,470.2000 | 652.9000 | -802 | 687.6000 | ||||||
Income Taxes | .1000 | .1000 | .0800 | .0700 | .0800 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 931.8000 | 1,470.1000 | 652.8000 | -802.1000 | 687.5000 |
Per Share
Cash Flow
2013 US GAAP in mill. CHF |
2014 US GAAP in mill. CHF |
2015 US GAAP in mill. CHF |
2016 US GAAP in mill. CHF |
2017 US GAAP in mill. CHF |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 117.1000 | 121.7000 | 52.4000 | 115.4000 | 263.5000 | ||||||
Cash Flow from Investing Activities | - | - | - | - | - | ||||||
Cash Flow from Financing | -92.6000 | -157.3000 | -39 | -126.8000 | -263 | ||||||
Decrease / Increase in Cash | 24.8000 | -34.7000 | 12.1000 | -10.8000 | .5000 | ||||||
Employees | - | - | - | - | - |